Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Mankind Pharma is a leading Indian pharmaceutical company dedicated to manufacturing and marketing high-quality, affordable medicines. With a strong focus on Research & Development, the company provides millions of patients with essential drugs across diverse therapeutic areas, significantly contributing to improved healthcare accessibility and outcomes.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Mankind Pharma is scheduled to report its next quarterly earnings on 10/26/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Mankind Pharma last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 13.80 INR.
Across its last 5 earnings reports, Mankind Pharma stock moved by ±2.6% on average the following day. The largest reaction was +4.8% on 02/03/2026; 2 of 5 reactions were positive.
Mankind Pharma has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.